| Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis DO Clegg, DJ Reda, CL Harris, MA Klein, JR O'Dell, MM Hooper, ... New England Journal of Medicine 354 (8), 795-808, 2006 | 2149 | 2006 |
| Psoriatic arthritis: epidemiology, clinical features, course, and outcome DD Gladman, C Antoni, P Mease, DO Clegg, P Nash Annals of the rheumatic diseases 64 (suppl 2), ii14-ii17, 2005 | 2042 | 2005 |
| Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial JC Davis Jr, D Van Der Heijde, J Braun, M Dougados, J Cush, DO Clegg, ... Arthritis & Rheumatism 48 (11), 3230-3236, 2003 | 1001 | 2003 |
| Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study DO Clegg, DJ Reda, E Mejias, GW Cannon, MH Weisman, T Taylor, ... Arthritis & Rheumatism 39 (12), 2013-2020, 1996 | 612 | 1996 |
| Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans … DO Clegg, DJ Reda, M Abdellatif Arthritis & Rheumatism: Official Journal of the American College of …, 1999 | 500 | 1999 |
| Minocycline in rheumatoid arthritis: a 48-week, double-blind, placebo-controlled trial BC Tilley, GS Alarcon, SP Heyse, DE Trentham, R Neuner, DA Kaplan, ... Annals of internal medicine 122 (2), 81-89, 1995 | 471 | 1995 |
| A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases D Jawaheer, MF Seldin, CI Amos, WV Chen, R Shigeta, J Monteiro, ... The American Journal of Human Genetics 68 (4), 927-936, 2001 | 437 | 2001 |
| The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial AD Sawitzke, H Shi, MF Finco, DD Dunlop, CO Bingham III, CL Harris, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 415 | 2008 |
| Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT AD Sawitzke, H Shi, MF Finco, DD Dunlop, CL Harris, NG Singer, ... Annals of the rheumatic diseases 69 (8), 1459-1464, 2010 | 399 | 2010 |
| Comparison of naproxen and acetaminophen in a two‐year study of treatment of osteoarthritis of the knee H James Williams, JR Ward, MJ Egger, R Neuner, RH Brooks, DO Clegg, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1993 | 368 | 1993 |
| Treatment of rheumatoid arthritis with oral type II collagen: results of a multicenter, double‐blind, placebo‐controlled trial ML Barnett, JM Kremer, EW St. Clair, DO Clegg, D Furst, M Weisman, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1998 | 338 | 1998 |
| Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study DO Clegg, DJ Reda, MH Weisman, WD Blackburn, JJ Cush, GW Cannon, ... Arthritis & Rheumatism 39 (12), 2004-2012, 1996 | 337 | 1996 |
| Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families D Jawaheer, MF Seldin, CI Amos, WV Chen, R Shigeta, C Etzel, A Damle, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2003 | 278 | 2003 |
| Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate CW Carson, GW Cannon, MJ Egger, JR Ward, DO Clegg Seminars in arthritis and rheumatism 16 (3), 186-195, 1987 | 268 | 1987 |
| Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks JC Davis, DM van der Heijde, J Braun, M Dougados, J Cush, D Clegg, ... Annals of the rheumatic diseases 64 (11), 1557-1562, 2005 | 253 | 2005 |
| Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study DO Clegg, DJ Reda, MH Weisman, JJ Cush, FB Vasey, ... Arthritis & Rheumatism 39 (12), 2021-2027, 1996 | 227 | 1996 |
| Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis JC Davis, DM van der Heijde, J Braun, M Dougados, DO Clegg, AJ Kivitz, ... Annals of the rheumatic diseases 67 (3), 346-352, 2008 | 220 | 2008 |
| Evaluation of the PROMIS physical function item bank in orthopaedic patients M Hung, DO Clegg, T Greene, CL Saltzman Journal of Orthopaedic Research 29 (6), 947-953, 2011 | 207 | 2011 |
| Psoriatic arthritis therapy: NSAIDs and traditional DMARDs P Nash, DO Clegg Annals of the rheumatic diseases 64 (suppl 2), ii74-ii77, 2005 | 204 | 2005 |
| Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. B Mulcahy, F Waldron-Lynch, MF McDermott, C Adams, CI Amos, DK Zhu, ... American journal of human genetics 59 (3), 676, 1996 | 200 | 1996 |
